Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		139,164,693
Beginning balance at Dec. 31, 2021	$ 389,700	$ 1	$ 848,229	$ (1)	$ (458,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	14,930		14,930
Exercise of stock options (in shares)		376,578
Exercise of stock options	1,517		1,517
Vesting of restricted stock units (in shares)		32,145
Vesting of restricted stock units	0		0
Cumulative translation adjustment	10			10
Net loss	(25,649)				(25,649)
Ending balance (in shares) at Mar. 31, 2022		139,573,416
Ending balance at Mar. 31, 2022	380,508	$ 1	864,676	9	(484,178)
Beginning balance (in shares) at Dec. 31, 2022		145,013,786
Beginning balance at Dec. 31, 2022	339,310	$ 1	951,946	(233)	(612,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	28,733		28,733
Exercise of stock options (in shares)		355,516
Exercise of stock options	1,449		1,449
Vesting of restricted stock units (in shares)		1,257,722
Vesting of restricted stock units	0		0
Other comprehensive loss	137			137	0
Cumulative translation adjustment	(11)
Net loss	(44,544)				(44,544)
Ending balance (in shares) at Mar. 31, 2023		146,627,024
Ending balance at Mar. 31, 2023	$ 325,085	$ 1	$ 982,128	$ (96)	$ (656,948)